Hitto Kaufmann's most recent trade in Pieris Pharmaceuticals Inc was a trade of 249,080 Stock Option (Right to buy) done . Disclosure was reported to the exchange on Feb. 24, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Pieris Pharmaceuticals Inc | Hitto Kaufmann | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 249,080 | 249,080 | - | - | Stock Option (Right to buy) | |
Pieris Pharmaceuticals Inc | Hitto Kaufmann | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 215,819 | 215,819 | - | - | Stock Option (Right to buy) | |
Pieris Pharmaceuticals Inc | Hitto Kaufmann | SVP, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 220,000 | 220,000 | - | - | Stock Options (Right to buy) |